{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:50:51Z","timestamp":1696233051322},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1007\/s11938-003-0021-x","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T18:25:44Z","timestamp":1180895144000},"page":"289-297","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of functional dyspepsia"],"prefix":"10.1007","volume":"6","author":[{"given":"Christine","family":"Feinle-Bisset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"suppl 2","key":"21_CR1","first-page":"37","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading RC, et al.: Functional gastroduodenal disorders. Gut 1999, 45(suppl 2):37\u201342.","journal-title":"Gut"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0016-5085(92)90764-P","volume":"102","author":"NJ Talley","year":"1992","unstructured":"Talley NJ, Zinsmeister AR, Schleck CD, et al.: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992, 102:1259\u20131268.","journal-title":"Gastroenterology"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1080\/003655299750026010","volume":"34","author":"V Meineche-Schmidt","year":"1999","unstructured":"Meineche-Schmidt V, Talley NJ, Pap A, et al.: Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multi-centre 3-month follow-up study. Scand J Gastroenterol 1999, 34:566\u2013574.","journal-title":"Scand J Gastroenterol"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11894-001-0071-y","volume":"3","author":"J Tack","year":"2001","unstructured":"Tack J, Bisschops R, DeMarchi B: Causes and treatment of functional dyspepsia. Curr Gastroenterol Rep 2001, 3:503\u2013508.","journal-title":"Curr Gastroenterol Rep"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.1995.tb00359.x","volume":"9","author":"NJ Talley","year":"1995","unstructured":"Talley NJ: Review article: functional dyspepsia\u2014should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995, 9:107\u2013115.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","volume":"121","author":"J Tack","year":"2001","unstructured":"Tack J, Caenepeel P, Fischler B, et al.: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001, 121:526\u2013535.","journal-title":"Gastroenterology"},{"key":"21_CR7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346\u20131352.","journal-title":"Gastroenterology"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V Stanghellini","year":"1996","unstructured":"Stanghellini V, Tosetti C, Paternico A, et al.: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110:1036\u20131042.","journal-title":"Gastroenterology"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","volume":"109","author":"L Agreus","year":"1995","unstructured":"Agreus L, Svardsudd K, Nyren O, et al.: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671\u2013680.","journal-title":"Gastroenterology"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004836-199806000-00022","volume":"26","author":"JS Finney","year":"1998","unstructured":"Finney JS, Kinnersley N, Hughes M, et al.: Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998, 26:312\u2013320.","journal-title":"J Clin Gastroenterol"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.2000.00742.x","volume":"14","author":"C Mansi","year":"2000","unstructured":"Mansi C, Borro P, Giacomini M, et al.: Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000, 14:561\u2013569.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2036.2000.00868.x","volume":"14","author":"NJ Talley","year":"2000","unstructured":"Talley NJ, Verlinden M, Snape W, et al.: Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000, 14:1653\u20131661. Large study demonstrating the failure of a motilin agonist to relieve symptoms in functional dyspepsia.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1053\/gast.2002.30295","volume":"122","author":"J Tack","year":"2002","unstructured":"Tack J, Delia T, Ligozio G, et al.: A phase II placebo controlled randomized trial with tegaserod (T) in functional dyspepsia (FD) patients with normal gastric emptying. Gastroenterology 2002, 122(suppl):A20.","journal-title":"Gastroenterology"},{"key":"21_CR14","first-page":"185","volume":"48","author":"F Halter","year":"1997","unstructured":"Halter F, Staub P, Hammer B, et al.: Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. J Physiol Pharmacol 1997, 48:185\u2013192.","journal-title":"J Physiol Pharmacol"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.35.3.327","volume":"35","author":"LE Troncon","year":"1994","unstructured":"Troncon LE, Bennett RJ, Ahluwalia NK, et al.: Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994, 35:327\u2013332.","journal-title":"Gut"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1007\/BF02300383","volume":"39","author":"A Berstad","year":"1994","unstructured":"Berstad A, Hausken T, Gilja OH, et al.: Volume measurements of gastric antrum by 3-D ultrasonography and flow measurements through the pylorus by duplex technique. Dig Dis Sci 1994, 39:97S-100S.","journal-title":"Dig Dis Sci"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00042737-199511000-00007","volume":"7","author":"R Barbera","year":"1995","unstructured":"Barbera R, Feinle C, Read NW: Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995, 7:1051\u20131057.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/BF02212683","volume":"40","author":"R Barbera","year":"1995","unstructured":"Barbera R, Feinle C, Read NW: Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995, 40:1636\u20131641.","journal-title":"Dig Dis Sci"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2982.2002.00318.x","volume":"14","author":"C Feinle","year":"2002","unstructured":"Feinle C, Christen M, Grundy D, et al.: Effects of duodenal fat, protein or mixed-nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans. Neurogastroenterol Motil 2002, 14:205\u2013213.","journal-title":"Neurogastroenterol Motil"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","volume":"48","author":"C Feinle","year":"2001","unstructured":"Feinle C, Meier O, Otto B, et al.: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48:347\u2013355. Laboratory-based study in a relatively small number of patients suggesting a beneficial effect of the cholecystokinin-A receptor antagonist dexloxiglumide on duodenal lipid- and gastric distension-induced nausea, fullness, and bloating. The effect appears to be independent of any changes in proximal gastric relaxation.","journal-title":"Gut"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/gast.2001.23232","volume":"120","author":"C Feinle","year":"2001","unstructured":"Feinle C, Rades T, Otto B, et al.: Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 2001, 120:1100\u20131107.","journal-title":"Gastroenterology"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","volume":"318","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Janssens J, Lauritsen R, et al.: Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months\u2019 follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999, 318:833\u2013837.","journal-title":"BMJ"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","volume":"324","author":"N Chiba","year":"2002","unstructured":"Chiba N, Van Zanten SJ, Sinclair P, et al.: Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002, 324:1012\u20131016. The results from this Canadian study indicate a benefit from adopting a \u201ctest and treat Helicobacter pylori\u201d strategy in symptom and cost reduction in uninvestigated dyspepsia.","journal-title":"BMJ"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00042737-200201000-00011","volume":"14","author":"A Madisch","year":"2002","unstructured":"Madisch A, Hotz J, Grabowski G, et al.: Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study. Eur J Gastroenterol Hepatol 2002, 14:61\u201369.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","volume":"16","author":"P Malfertheiner","year":"2002","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain C, et al.: Current concepts in the management of Helicobacter pylori infection-the Maastricht 2\u20132000 Consensus Report. Aliment Pharmacol Ther 2002, 16:167\u2013180.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Pare P, et al.: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998, 12:1055\u20131065.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1046\/j.1365-2036.2001.01044.x","volume":"15","author":"HA Redstone","year":"2001","unstructured":"Redstone HA, Barrowman N, Veldhuyzen Van Zanten SJ: H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001, 15:1291\u20131299.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00006842-199903000-00005","volume":"61","author":"P Herschbach","year":"1999","unstructured":"Herschbach P, Henrich G, von Rad M: Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behavior? Psychosom Med 1999, 61:148\u2013153.","journal-title":"Psychosom Med"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gut.43.2.256","volume":"43","author":"EJ Bennett","year":"1998","unstructured":"Bennett EJ, Tennant CC, Piesse C, et al.: Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998, 43:256\u2013261.","journal-title":"Gut"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.2001.tb05819.x","volume":"933","author":"H Ursin","year":"2001","unstructured":"Ursin H, Eriksen HR: Sensitization, subjective health complaints, and sustained arousal. Ann N Y Acad Sci 2001, 933:119\u2013129.","journal-title":"Ann N Y Acad Sci"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/gast.1997.v113.pm9247458","volume":"113","author":"AM Accarino","year":"1997","unstructured":"Accarino AM, Azpiroz F, Malagelada JR: Attention and distraction: effects on gut perception. Gastroenterology 1997, 113:415\u2013422.","journal-title":"Gastroenterology"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1572-0241.1999.00781.x","volume":"94","author":"F Mearin","year":"1999","unstructured":"Mearin F, Balboa A, Zarate N, et al.: Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 1999, 94:116\u2013125.","journal-title":"Am J Gastroenterol"},{"key":"21_CR33","first-page":"1082","volume":"115","author":"Y Li","year":"2002","unstructured":"Li Y, Nie Y, Sha W, et al.: The link between psychosocial factors and functional dyspepsia: an epidemiological study. Chin Med J (Engl) 2002, 115:1082\u20131084.","journal-title":"Chin Med J (Engl)"},{"key":"21_CR34","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(01)06581-3","volume":"358","author":"DS Sanders","year":"2001","unstructured":"Sanders DS, Carter MJ, Hurlstone DP, et al.: Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001, 358:1504\u20131508.","journal-title":"Lancet"},{"key":"21_CR35","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"EL Calvert","year":"2002","unstructured":"Calvert EL, Houghton LA, Cooper P, et al.: Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002, 123:1778\u20131785. Comprehensive study demonstrating the long-term beneficial effect of hypnotherapy on symptoms and quality of life in functional dyspepsia.","journal-title":"Gastroenterology"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J Hamilton","year":"2000","unstructured":"Hamilton J, Guthrie E, Creed F, et al.: A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000, 119:661\u2013669.","journal-title":"Gastroenterology"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1023\/A:1015370430477","volume":"47","author":"MR Poitras","year":"2002","unstructured":"Poitras MR, Verrier P, So C, et al.: Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life. Dig Dis Sci 2002, 47:1297\u20131307.","journal-title":"Dig Dis Sci"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-3999(94)90026-4","volume":"38","author":"TT Haug","year":"1994","unstructured":"Haug TT, Wilhelmsen I, Svebak S, et al.: Psychotherapy in functional dyspepsia. J Psychosom Res 1994, 38:735\u2013744.","journal-title":"J Psychosom Res"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1053\/gast.2002.37286","volume":"123","author":"OS Palsson","year":"2002","unstructured":"Palsson OS, Whitehead WE: The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders. Gastroenterology 2002, 123:2132\u20132135. Editorial summarizing the available evidence for psychologic treatments of functional gastrointestinal disorders. The conclusions are in strong favor of further use, and the further evaluation of hypnotherapy in particular.","journal-title":"Gastroenterology"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"NW Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664\u2013668.","journal-title":"Gut"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15:525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2036.2002.01180.x","volume":"16","author":"E Distrutti","year":"2002","unstructured":"Distrutti E, Fiorucci S, Hauer SK, et al.: Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther 2002, 16:613\u2013622.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR43","first-page":"A471","volume":"112","author":"M Bortolotti","year":"2002","unstructured":"Bortolotti M, Coccia G, Grossi G, et al.: Treatment of functional dyspepsia with red pepper. Gastroenterology 2002, 112(suppl):A471.","journal-title":"Gastroenterology"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1572-0241.2002.05421.x","volume":"97","author":"GE Boeckxstaens","year":"2002","unstructured":"Boeckxstaens GE, Hirsch DP, Kuiken SD, et al.: The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002, 97:40\u201348.","journal-title":"Am J Gastroenterol"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(99)70179-4","volume":"116","author":"M Thumshirn","year":"1999","unstructured":"Thumshirn M, Camilleri M, Choi MG, et al.: Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999, 116:573\u2013585.","journal-title":"Gastroenterology"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2982.2000.00184.x","volume":"12","author":"S Vingerhagen","year":"2000","unstructured":"Vingerhagen S, Hausken T, Gilja OH, et al.: Influence of a 5HT1 receptor agonist on gastric accommodation and initial transpyloric flow in healthy subjects. Neurogastroenterol Motil 2000, 12:95\u2013101.","journal-title":"Neurogastroenterol Motil"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1365-2036.2000.00873.x","volume":"14","author":"B May","year":"2000","unstructured":"May B, Kohler S, Schneider B: Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 2000, 14:1671\u20131677. Interesting study on the effect of an herbal preparation on symptom improvement in functional dyspepsia. The magnitude of the effect is comparable with that of other therapies.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-003-0021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-003-0021-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:58Z","timestamp":1559437018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-003-0021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11938-003-0021-x","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}